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Despite increasing knowledge on microRNAs, their role in the pathogenesis of neonatal
encephalopathy remains to be elucidated. Herein, we identify let-7b-5p as a significant
microRNA in neonates with moderate to severe encephalopathy from dried blood spots using
next generation sequencing. Validation studies using Reverse Transcription and quantitative
Polymerase Chain Reaction on 45 neonates showed that let-7b-5p expression was increased
on day 1 in neonates with moderate to severe encephalopathy with unfavourable outcome
when compared to those with mild encephalopathy. Mechanistic studies performed on glu-
cose deprived cell cultures and the cerebral cortex of two animal models of perinatal brain
injury, namely hypoxic-ischaemic and intrauterine inflammation models confirm that let-7b-
5p is associated with the apoptotic Hippo pathway. Significant reduction in neuronal let-7b-
5p expression corresponded with activated Hippo pathway, with increased neuronal/nuclear
ratio of Yes Associated Protein (YAP) and increased neuronal cleaved caspase-3 expression
in both animal models. Similar results were noted for let-7b-5p and YAP expression in
glucose-deprived cell cultures. Reduced nuclear YAP with decreased intracellular let-7b-5p
correlated with neuronal apoptosis in conditions of metabolic stress. This finding of the
Hippo-YAP association with let-7b needs validation in larger cohorts to further our knowl-
edge on let-7b-5p as a biomarker for neonatal encephalopathy.
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Neonatal encephalopathy (NE) such as that associated withperinatal hypoxia-ischaemia remains an important causeof morbidity and mortality in term-born neonates
globally1. Mild therapeutic hypothermia (TH) has been shown to
reduce death or severe neurodisability with a number needed to
treat of seven to nine2,3. Improved understanding of the patho-
physiology of NE is important in identifying reliable biomarkers
and more effective treatments. Potentially microRNAs may have
an important role in the pathophysiology of NE4.
MicroRNAs (miRNAs), a group of small noncoding RNAs made
up of 17–22 nucleotides, are important regulators of a number of
processes in health and disease, in conditions including cancer5,
cardiovascular disease6, inflammatory disorders7 and immature
brain injury4. There are relatively few studies on the role of miR-
NAs in NE, using neonatal blood samples8,9 and umbilical cord
samples10,11. Hence in the present study, we set out to identify
candidate miRNAs from blood samples of newborns with NE and
to investigate the corresponding cellular and molecular mechanisms
linked to these miRNAs through the use of in vitro and in vivo
models of NE.
In our analysis of miRNA next-generation sequencing (NGS)
of neonates with NE, the apoptotic Hippo signalling pathway was
identified to be associated with a number of miRNAs that were
differentially expressed between the favourable and unfavourable
outcome groups, in particular the miRNA let-7b-5p. The Hippo
signalling pathway is an important, well-conserved pathway
known to function across a number of mammalian species12,13
with a role in regulating apoptosis and cell proliferation. Within
this pathway, there are kinase complexes that negatively regulate
the activities of the mammalian Yorkie (YKi) homologue named
Yes Associated Protein (YAP) and transcriptional coactivator
with PDZ-binding motif (TAZ).
The function of the Hippo pathway is dependent on the
translocation of YAP/TAZ from the cytoplasm into the nucleus.
In physiological conditions, the Hippo pathway is not activated so
the YAP/TAZ complex remains unphosphorylated and is trans-
located into the nucleus. In the nucleus, YAP/TAZ bind to
Transcription enhancer factor-1 (TEA/TEF) domain transcrip-
tion factors 1–4 (TEAD 1–4), which are key DNA-binding plat-
forms for YAP/TAZ to regulate cell growth in humans14. The
nuclear YAP/TAZ/TEAD protein complex transcribes anti-
apoptotic genes and maintains cell survival15. However, in
pathological conditions such as stress, activation of the Hippo
pathway leads to activation of YAP through phosphorylation. The
phosphorylated YAP/TAZ remains in the cytoplasm and under-
goes proteolytic degradation. In our study, we show using both
in vitro and in vivo models of NE that neuronal apoptosis is
associated with a decrease in let-7b-5p and a reduced nuclear
location of YAP. This indicates a potential role of the Hippo
pathway in the cell death associated with NE.
Results
Identification of candidate and endogenous control miRNAs in
moderate to severe neonatal encephalopathy using miRNA
next-generation sequencing. From the four cohorts of neonates
(1A: moderate to severe NE with TH and favourable outcome, 1B:
moderate to severe NE with TH and unfavourable outcome, 2:
mild NE without TH, 3: healthy cord blood, n= 4 per group) a
total of 2795 miRNAs were identified in the miRNA NGS analysis
performed using dried blood spots (DBS). Unsupervised data
analysis using principal component analysis (PCA) did not reveal
any unique clustering based on any of the simple parameters (i.e.
time, injury or outcome) (Fig. 1a). A number of miRNAs were
differentially expressed between the groups with unadjusted p
value < 0.05 (Fig. 1b) and the heatmap generated after correcting
for false discovery rate (FDR) < 0.05 revealed 17 significant
miRNAs (Fig. 1c) which were differentially expressed in healthy
cord blood compared to that of neonatal blood samples. On
removing umbilical cord blood samples from the analysis, and
correcting for FDR, there were no miRNAs that had a significant
differential expression between the three remaining groups
(Fig. 1d) as demonstrated in the heatmap (Fig. 1e).
Among the neonates with NE, there was a pool of
134 significant miRNAs differentially expressed between the mild
NE and moderate to severe NE with favourable and unfavourable
outcome groups. Of these, (top 10 in descending order of
significance), miR-29b-3p, miR-3200-3p, let-7b-3p, miR-3682-3p,
miR-337-5p, miR-3200-5p, let-7b-5p, miR-412-5p, miR-4467 and
miR-548 were noted to have the most significant p value
attributes. Using hierarchical clustering analysis, let-7b-5p, let-
7b-3p and miR-3200-3p were identified as the most differentially
expressed miRNAs between the favourable and unfavourable
outcome groups (Fig. 2). KEGG pathway analysis of all 134
miRNAs identified multiple pathways involving a number of
miRNAs with p values < 0.05 (Fisher’s exact test) after applying
FDR correction. Since NE is associated with cell death, the
apoptotic pathways were studied4. KEGG analysis identified three
apoptotic pathways, namely the Hippo signalling pathway,
P53 signalling pathway and Lysine degradation pathway.
However, the only apoptotic pathway to differentially express
both let-7b-3p and let-7b-5p between the Group 1 neonates with
favourable and unfavourable outcome was the Hippo signalling
pathway. The use of reverse pathway analysis of the Hippo
pathway confirmed let-7b-5p to be in the top 10 most significant
miRNAs of all the 771 miRNAs involved in this pathway. Using
Normfinder, miR-454-5p was identified as a suitable endogenous
control from 2795 miRNAs detected in the NGS analysis, with a
good stability value of 0.68. Following NGS data analysis, let-7b-
3p, let-7b-5p and miR-3200-3p were studied for validation as
candidate miRNAs along with miR-454-5p as endogenous control
in the next step using Reverse Transcription and quantitative
Polymerase Chain Reaction (RT-qPCR).
Validation of control and candidate miRNAs through RT-
qPCR. Independent validation of the endogenous control and
three candidate miRNAs was performed on the three neonatal
subgroups (1 A, 1B and 2; n= 15 each) after excluding umbilical
cord blood samples. Neonates in Group 1 (moderate to severe NE
with TH) had a significantly lower Apgar score at 10 min, were
more likely to require respiratory support and need chest com-
pressions compared to those in Group 2 (mild NE without TH) as
shown in Table 1. There was a higher proportion of male neo-
nates in Group 1, particularly in the unfavourable outcome group
when compared to Group 2, although this was not statistically
significant. We have shown that there was a strong correlation
between the MRI outcome and two-year neurodevelopmental
outcome in this cohort16. Table 1 shows that most neonates in
unfavourable MRI group had substantial degree of brain injury
with higher scores in all the regions, namely basal ganglia and
thalamus, posterior limb of the internal capsule, white matter and
cerebral cortex according to the scoring system used17. Of the
neonates with moderate to severe NE treated with TH, all those in
the favourable MRI group had a normal neurodevelopmental
outcome as opposed to only one in the unfavourable MRI group
at a median age of 2.5 years. Eleven children in the unfavourable
MRI group developed cerebral palsy.
MiR-454-5p was validated as a reliable endogenous control
miRNA with stable expression across all groups (Fig. 3a) and time
points (Sample 1 (S1)—Day 1, Sample 2 (S2)—Day 2–3 and Sample
3 (S3)—Day 5) (Fig. 3b) (Supplementary Data 1). Let-7b-5p
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Fig. 1 Identification of candidate miRNA through miRNA next-generation sequencing. a PCA plot of all neonates examined with miRNA NGS according
to their groups (Group 1A: moderate to severe NE with TH and favourable outcome (purple hexagon; S1, purple diamond; S2, purple square; S3), Group 1B:
moderate to severe NE with TH and unfavourable outcome (green hexagon; S1, green diamond; S2, green square; S3), Group 2: mild NE without TH (blue
circle), and Group 3: umbilical cord blood of healthy neonates (red circles). b Venn diagram showing the number of significant differential expression of
miRNA between all three groups with umbilical cord blood. c Heatmap of all neonates in miRNA NGS with 17 significant miRNAs. d Venn diagram showing
the differential expression of miRNA between all three groups excluding umbilical cord blood. e Heatmap of all neonates in miRNA NGS excluding umbilical
cord blood showing no significant miRNAs.
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expression in S1 samples exhibited a significant increase in
moderate to severe NE with TH and unfavourable outcome
compared to mild NE without TH (p= 0.019) (Fig. 3c), while there
was no significant change in temporal expression in Group 1
neonates between the outcome groups or other time points (Fig. 3d).
However, let-7b-3p and miR-3200-3p did not demonstrate any
differential expression both at S1 between all 3 groups or on
temporal expression data at different time points on S1, S2 and
S3 samples (Fig. 3e–h) (Supplementary Data 1). There was no
statistical difference in the expression of all three candidate miRNAs
between males and females within the groups. Because of the
significant differential expression of let-7b-5p in neonates with NE,
it was further studied in vitro and in two animal models of NE to
further understand the mechanistic pathway.
Validation of neuronal apoptosis in glucose-deprived in vitro
cell cultures. In order to study the apoptotic Hippo pathway, we
first studied cleaved caspase-3 expression in the neuronal cells of
an in vitro primary mixed cell cultures using glucose deprivation
to mimic metabolic stress. There was significant increase in
(mean+ / SEM) cleaved caspase-3 expression in the neuronal
cells of glucose-deprived cell cultures (79.75+ /− 2.06) when
compared to control cell cultures (53.58+ /− 0.74) (Fig. 4a,
Fig. 4b) (Supplementary Data 2).
Reduced expression of let-7b-5p and YAP in glucose-deprived
neuronal cells in vitro. Let-7b-5p expression in neurones was
studied in the in vitro NE model following confirmation of
apoptosis in the cell cultures under glucose-deprived conditions.
In comparison with control cell cultures, glucose-deprived cul-
tures showed significantly reduced expression (mean+ /− SEM)
of total let-7b-5p immunostaining area (13.1+ /− 1.6 vs.
5.6 ± 0.6 A.U., p= 0.004) (Fig. 5a, Fig. 5b). More specifically, let-
7b-5p expression in NeuN positive neuronal cells was sig-
nificantly reduced (50.78+ /− 1.36 vs. 11.23+ /− 1.10 % area,
p < 0.001) (Fig. 5c) as was the percentage of neuronal let-7b-5p
positive cells (99.96+ /− 0.04 vs. 79.94+ /− 8.31, p= 0.03),
confirming that the majority of let-7b-5p positive cells was neu-
ronal (Fig. 5d) (Supplementary Data 2).
YAP, a core component of the Hippo signalling pathway, was
studied in neuronal cells in the in vitro NE model as the KEGG
analysis highlighted the significance of the apoptotic Hippo
pathway in neonates with NE. Because a reduction in nuclear to
cytoplasmic YAP expression is important to demonstrate an
activated Hippo pathway,18 co-immunostaining of YAP and
NeuN, with Hoechst staining of the nucleus, was carried out to
identify the neuronal (cytoplasmic) and nuclear YAP expression
separately, as clearly observed (Fig. 5e). Neuronal /nuclear YAP
ratio (mean+ /− SEM) in glucose-deprived neuronal cells was
significantly higher (2.32+ /− 0.07 vs. 1.67+ /− 0.08, p < 0.001)
when compared to control neuronal cells (Fig. 5f). This
significant change in ratio was due to both a significant reduction
(mean+ /− SEM) in nuclear YAP expression (21.21+ /− 0.81 vs.
28.39+ /− 0.73, p < 0.001) (Fig. 5g) and a significant increase in
neuronal cytoplasmic YAP expression (50.1+ /− 1.84 vs.
44.16+ /− 1.07, p= 0.007) (Fig. 5h) in glucose-deprived
neuronal cells compared to neuronal cells in normal control
Fig. 2 Hierarchical clustering analysis of all the differentially expressed miRNAs by outcome. Hierarchical clustering analysis using the R program
showing let-7b in the forms of 3p and 5p strands to be the most significantly changed miRNA in the moderate to severe NE neonates with TH treatment
based on outcome. F1, F3 and F5 represent favourable outcome on days 1, 3 and 5 respectively; while U1, U3 and U5 represent unfavourable outcome on
days 1, 3 and 5 respectively.
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conditions (Supplementary Data 2). These findings suggest
activation of the Hippo pathway leading to increased neuronal
YAP and reduced nuclear YAP, associated with reduced let-7b-5p
expression under metabolic stress.
Neuronal cell death in the cerebral cortex of rat neonatal
encephalopathy models. Two animal models of NE were studied
as these may correspond to clinical NE in the human setting more
closely. In the cerebral cortex, cleaved caspase-3 expression
representing apoptotic cell death was significantly increased
(mean+ /− SEM) in hypoxic-ischaemic pups on the ipsilateral
side (45.9+ /− 0.4, p= 0.004), contralateral side (51.9+ /− 3.6,
p < 0.001) and the intrauterine inflammatory model pups
(42.4+ /− 1.1, p= 0.006) when compared to control pups
(30.0+ /− 3.4) (Fig. 6a, Fig. 6b). However, the total number of
neuronal cleaved caspase-3 positive cells was not significantly
different between the animal models (p value= 0.37, Fig. 6c)
(Supplementary Data 3).
Let-7b-5p expression in the rat neonatal encephalopathy
models. After confirming the presence of apoptosis in the NE
models, let-7b-5p expression was studied in the cerebral cortex of
both NE models in comparison to the control pups. Combined
fluorescent in situ hybridisation (FISH) and immunohistochem-
istry (IHC) analysis using NeuN showed that let-7b-5p was
predominantly expressed in cerebral cortical neurones (Fig. 7a).
In the cerebral cortex, the percentage of neuronal let-7b-5p
expression (mean+ /− SEM) in comparison to the control pups
was significantly reduced in both ipsilateral (69.9+ /− 2.3,
p < 0.001) and contralateral (74.0+ /− 2.8, p < 0.001) sides in the
hypoxic-ischaemic model and the intrauterine inflammation
model (71.4+ /− 5.8, p < 0.001) (Fig. 7b) (Supplementary
Data 3).
As for the human neonatal samples, let-7b-5p and let-7b-3p
expressions were studied in the DBS of peripheral blood of NE
animal models to understand the peripheral expression pattern.
The relative quantification of let-7b-5p normalised to miR-454-5p
in the peripheral blood of rat pups showed that there was a
significant decrease in expression (mean+ /− SEM) in the
intrauterine inflammation model (0.28+ /− 0.09, p= 0.022), but
not hypoxic-ischaemic model (0.90+ /− 0.27, p= 0.86) when
compared to the control (1.0+ /− 0.17) (Fig. 7c). However, the
relative expression of let-7b-3p normalised to miR-454-5p
(mean+ /− SEM) in hypoxic-ischaemic model (1.89+ /− 0.43)
and intrauterine inflammation model (1.89+ /− 1.24) were not
significantly different to the control (1.31+ /− 0.46) (overall p
value= 0.90) (Fig. 7d) (Supplementary Data 3). This suggests that
there was an alteration only in peripheral let-7b-5p expression
after intrauterine inflammation. Similar to the in vitro NE model,
let-7b-5p was confirmed to be differentially expressed both in
peripheral blood and cerebral cortical tissue in the NE animal
models when compared to control pups.
Alteration in YAP expression of Hippo pathway in the rat
neonatal encephalopathy models. To understand the relation-
ship between let-7b-5p and the Hippo pathway in the in vivo
models, YAP expression was studied in the cerebral cortex of
both the NE animal models in comparison to the control pups
(Fig. 8a) as for the cell cultures using co-staining between the
NeuN with YAP (neuronal, Fig. 8b) and YAP with Hoechst
(nuclear, Fig. 8c).
In the cerebral cortex, there was a significant increase in the
ratio of neuronal to nuclear YAP in NE animal models when
compared to control pups (Fig. 8d). The neuronal/nuclear
YAP ratio was significantly higher (mean+ /− SEM) in
hypoxic-ischaemic pups, ipsilateral side (0.92+ /− 0.01,
p < 0.001) and contralateral side (1.0+ /− 0.05, p < 0.001),
Table 1 Clinical characteristics of patient samples analysed by RT-qPCR for the validation cohort.
Perinatal characteristics Moderate to severe NE with TH and
favourable MRI outcome
(Group 1A) n= 15
Moderate to severe NE with TH
and unfavourable MRI outcome
(Group 1B) n= 15
Mild NE without TH




40+ 4 (39+ 3– 41+ 4) 40+ 2 (38+ 4–41) 40+ 2 (39+ 3–41+ 4) 0.430
Male sex, n (%) 10 (67%) 12 (80%) 6 (40%) 0.071
Birth weight (g) 3700 (3318–3905) 3240 (2745–3685) 3520 (3145–3972) 0.101
Apgar score at 10 min 5 (4–7) 4 (4–6) 9 (8–0) <0.001***
Worst pH within 1 h 6.88 (6.77–6.95) 6.87 (6.64–7.00) N/A 0.923
Worst base deficit within 1 h −17.45 (−14.12 to −20.85) −19.3 (−17 to −22.9) N/A 0.381
Need for respiratory support at
10 min, n (%)
12 (80%) 13 (87%) 4 (27%) 0.001**
Need for chest compressions,
n (%)
2 (13%) 6 (40%) 1 (7%) 0.038*
Antenatal sentinel event
present, n (%)
3 (20%) 1 (7%) N/A 0.598




13 (0), 2 (1), 0 (2), 0 (3)
15 (0), 0 (1), 0 (2)
11 (0), 3 (1), 1 (2), 0 (3)
2 (0), 0 (1), 5 (2), 8 (3)
2 (0), 3 (1), 10 (2),




15 (100%) 1 (7%) N/A <0.001***
Age at DBS sample S1
(decimal hours)
14.8 (10.8–21.1) 18.1 (12.4–21.1) 22.8
(14.9–32)
0.07
Age at DBS sample S2
(decimal hours)
60.2 (51.1–67.0) 54.6 (51.1–61.4) N/A 0.907
Age at DBS sample S3
(decimal hours)
97.8 (88.9–104.1) 95.4 (87.0–100.4) N/A 0.643
Values are median (IQR) unless indicated otherwise; N/A, Not Applicable; *, **, *** denote significant p < 0.05, p < 0.01, p < 0.001, respectively. NE neonatal encephalopathy, TH therapeutic hypothermia,
DBS dried blood spot. MRI were rated using a validated method17, with ranges of component scores for each of BG Basal Ganglia, PLIC Posterior Limb of the Internal Capsule, WM White Matter, CC
Cerebral Cortex. Neonates with an unfavourable outcome had a severe pattern of injury including reversed or abnormal signal intensity bilaterally on T1- and/or T2-weighted sequences in the posterior
limb of the internal capsule (PLIC); multifocal or widespread abnormal signal intensity in the basal ganglia and thalami (BGT); and severe widespread white matter (WM) lesions including infarction,
haemorrhage and long T1 and T2. Neonates with MRIs predictive of a favourable outcome had either normal images or less severe patterns of injury that are associated with normal or only mildly
abnormal neurodevelopmental outcomes. Consensus was reached in cases of disagreement. In this cohort we have shown that using this method, cerebral MRI is highly predictive of neurodevelopmental
outcome16.
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Fig. 3 Expression of control and candidate miRNAs in neonates with encephalopathy. a, c, e and g show the expression of miR-454-5p, let-7b-5p, let-7b-
3p and miR-3200-3p respectively in all groups at S1 samples. Similarly graphs b, d, f and h show the temporal expression of miR-454-5p, let-7b-5p, let-7b-
3p and miR-3200-3p, respectively, at various time points (S1, S2 and S3 samples) in neonates with moderate to severe NE with TH and favourable and
unfavourable outcome. Green bars represent favourable outcome, while purple bars represent unfavourable outcome. Neonates with mild NE not receiving
TH were denoted in grey bars. Relative quantification denotes 2-ΔΔCt of the candidate miRNAs in comparison to endogenous control miRNA, miR-454-5p.
Column graphs showing mean with error bars representing SEM. ns, not significant; * denote p < 0.05 using Kruskal–Wallis test for nonparametric data.
Each group consists of n= 15 neonates. NE neonatal encephalopathy, TH therapeutic hypothermia, Fav favourable outcome, Unfav unfavourable outcome.
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and in intrauterine inflammatory model pups (0.95+ /− 0.01,
p < 0.001) when compared to control pups (0.74+ /− 0.02),
indicating a higher proportion of neuronal cytoplasmic YAP
to nuclear YAP in the cerebral cortex of NE models (Fig. 8d).
This neuronal/nuclear YAP ratio received contribution from
the cytoplasmic YAP expression that was significantly higher
(mean+ /− SEM) in the hypoxic-ischaemic ipsilateral side
(40.5+ /− 3.7, p= 0.002), hypoxic-ischaemic contralateral
side (39.5+ /− 3.4, p= 0.003) and intrauterine inflammatory
model pups (38.3+ /− 2.3, p= 0.001) when compared to
control pups (25.8+ /− 0.63, overall p value= 0.0007)
(Fig. 8e). The nuclear YAP staining was not significantly
different in expression across both the NE animal modes
(p= 0.26) compared to control pups. (Fig. 8f) (Supplementary
Data 3). These results further confirmed that activation of the
Hippo pathway in the neurones of cerebral cortex in both NE
models leads to apoptosis.
Discussion
While miRNAs have been noted to be involved in a number of
pathophysiological processes in the central nervous system, our
understanding of their role in neonates with moderate to severe
NE is limited4. This study has used unbiased miRNA NGS to
identify candidate miRNAs from DBS in neonates that may be
associated with moderate to severe NE. Bioinformatic analysis
yielded let-7b-5p as a potential candidate and miR-454-5p as an
endogenous control miRNA. Furthermore, for the first time, we
report the association of let-7b-5p with the apoptotic Hippo
pathway in the context of NE, following validation of let-7b-5p in
an independent cohort of neonates with NE. To enable the study
of the cellular and molecular mechanism associated with let-7b-
5p and the Hippo pathway in NE, in vitro and in vivo models of
NE were used. In vitro, glucose-deprived neuronal cells
mimicking metabolic stress in NE showed a decrease in let-7b-5p,
an increase in cytoplasmic YAP expression and a reduction in
nuclear YAP expression. In animal models of NE, there was a
significant decrease in let-7b-5p expression in peripheral blood of
the rat intrauterine inflammation injury model and in the cere-
bral cortical neuronal cells of both the rat perinatal injury models.
This was associated with a significant increase in neuronal cleaved
caspase-3 expression and cytoplasmic YAP expression in the
cerebral cortex of both animal models, indicating neuronal
apoptosis linked to activation of the Hippo pathway.
Whilst little is known about let-7b-5p in NE, let-7b has been
observed to be expressed in the mammalian brain and has been
studied in a number of neurological conditions such as ischaemic
stroke19, glioma20 and dementia21. Let-7b has also been shown to
regulate neural stem cell proliferation and differentiation22,23.
Additionally, extracellular let-7b may be a strong activator for
Toll-like-Receptor signalling of the inflammatory pathway
involved in adult neuronal cell death24. In the present study, let-
Fig. 4 Neuronal apoptosis in normal and glucose-deprived neuronal cells in vitro. a Images of NeuN positive neuronal cells (green) with cleaved caspase-
3 (red) and coexpression is shown (yellow) in the control and glucose-deprived group. Arrows indicate coexpression. b Graph shows the significant
increase in neuronal cleaved caspase-3 expression after glucose-derivation compared to the control group. Error bars represent mean with SEM. n= 4. ****
denote significant p < 0.0001 using unpaired t test. Scale bar= 25 μm. CTL control.
COMMUNICATIONS BIOLOGY | https://doi.org/10.1038/s42003-021-02672-3 ARTICLE
COMMUNICATIONS BIOLOGY |          (2021) 4:1143 | https://doi.org/10.1038/s42003-021-02672-3 | www.nature.com/commsbio 7
7b-5p was predominantly expressed in neuronal cells in both the
NE animal models, with significant reduction in expression in the
cerebral cortex of pups with hypoxic-ischaemic injury and
intrauterine inflammation when compared to control pups.
Interestingly, we also noted a significant decrease in let-7b-5p
expression in the peripheral blood of pups of the intrauterine
inflammation model, but not the hypoxic-ischaemic injury
model. One possible explanation for this discrepancy may be
related to the time period from the insult given; the hypoxic-
ischaemic pups were euthanised at 24 h postinsult, while intrau-
terine inflammation pups had samples taken 9 days postinsult,
thus allowing more time for changes in brain miRNA to be
observed peripherally. This could also be due to an additional role
of let-7b in neuroinflammation acting through other pathways.
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Given the limited knowledge about the expression of let-7b-5p in
NE, the use of two different animal models with different injury
patterns allowed us to explore the let-7b-5p expression at the
cellular level. Cleaved caspase-3 positive apoptotic neuronal cell
death was significantly higher in the cerebral cortex of both the
NE models when compared to control pups. This is in agreement
with other studies showing activation of caspase-3 in neonatal
hypoxic-ischaemic models both in rodents25,26 and piglets27. The
corresponding reduction in let-7b-5p and increase in cleaved
caspase-3 expression highlights the potential role of let-7b-5p in
the neuronal apoptotic cell death pathway28.
Let-7b regulation has been noted to involve a number of targets
and pathways, including vascular endothelial growth factor29,
hypoxia-inducible factor30 and neuroinflammation24,31, which
are likely to be involved in the pathophysiology of NE. However,
to date, let-7b-5p has not been studied in clinical or animal
models of NE. Due to the presence of neuronal apoptosis in our
models, we studied the role of let-7b-5p in the Hippo pathway,
which was highlighted as one of the main apoptotic pathways
through KEGG analysis.
The main function of the Hippo pathway depends on the
translocation of YAP from the cytoplasm into the nucleus.
Recently, a reduction in nuclear YAP protein levels has been
correlated to reduced survival in Huntington’s disease32.
Although both the Hippo pathway and let-7b have been well
studied independently in a number of oncological conditions,
their role in NE remains to be explored in detail. In general,
nuclear YAP is a potent growth promoter, and let-7b has a well-
known tumour suppressor role33. We speculate that the interac-
tion between the nuclear YAP and let-7b-5p may be inverse in
order to maintain a normal environment with adequate cell
growth /differentiation through a complex feedback system
involving a number of antiapoptotic genes and possibly other
miRNAs. In NE, the downregulation of let-7b-5p and the
reduction in nuclear YAP could result in apoptotic neuronal
cell death.
Currently, knowledge about specific interactions between the
Hippo pathway and let-7b-5p is limited. A number of miRNAs
have been noted to both positively and negatively regulate the
Hippo pathway upstream34. On the other hand, the Hippo
pathway can also regulate let-7b either directly through Dicer
expression35, indirectly through Lin28 which is influenced by
phosphorylated Merlin, an upstream tumour suppressor in the
Hippo pathway34,36 or by p72 binding to the microprocessor
complex needed in the biogenesis of miRNAs37. Some of these
mechanisms also provide an association between the Hippo
pathway and biogenesis of other miRNAs, with or without
involving let-7b expression based on cell contact signals35,37.
There are complex feedback loops between various miRNAs and
the Hippo pathway, effectively controlling the expression of
nuclear YAP, which in turn regulates antiapoptotic genes and
thus controls cell growth and survival. Whilst our study has
highlighted the changes in expression of both the let-7b-5p and
the YAP protein in the Hippo pathway for the first time in
in vitro and in vivo NE models, the exact mechanism of the
interaction between the two needs to be explored further.
Our study has a number of strengths. We have used neonatal
samples from well-defined groups of babies with NE as a starting
point to identify differentially expressed miRNAs through
unbiased next-generation sequencing and further validated the
candidate miRNA in a larger independent cohort of neonates
using RT-qPCR. To the best of our knowledge, we have
demonstrated a novel mechanism for let-7b in NE associated with
the YAP protein of the Hippo pathway using both the in vitro and
in vivo models.
Studies using umbilical cord blood as a biosample source to
identify potential early biomarkers to stratify neonates with NE
have been reported38–40. However, using miRNA NGS, we
have also shown that umbilical cord blood has a different
miRNA profile compared to that of neonatal blood and thus is not
suitable as a control biosample for neonatal blood samples from
later time points. Finally, in this study, we have validated our ori-
ginal technique of using DBS for RT-qPCR8,9 to additionally per-
form miRNA NGS analysis. This would improve the feasibility of
performing future large-scale studies in the neonatal population.
The main limitations of our study are the relatively smaller
number of samples in each subgroup for various grades of NE in
the miRNA NGS study and the individual variations in the
sample collection times for the sequential blood samples. This
might explain the lack of clear identification of significant miR-
NAs differentially expressed between the groups of neonates with
varying degrees of NE. While the number of samples used pro-
vided the necessary power for statistical analysis, neonates with
encephalopathy are known to have a varying clinical presentation
that evolves with time. Therefore, a larger sample size in the
subgroups at precisely set time points would have been more
beneficial. We tried to reduce the clinical variations by selecting
the neonates in each subgroup using clear categorisation as
described in Supplementary Table 1. Additionally, as a novel
study on the mechanism of action of a miRNA, we used both the
peripheral blood and brain tissue of the animal models along with
cell cultures to study the changes seen in NE at a cellular level.
However, our work was done on P7 rat pups instead of P10 pups.
Although P7 rat pups have been extensively used in NE models,
they relate more to late preterm neonates of 32 to 34 weeks’
gestation instead of full-term neonates41,42. Whilst our technique
was robust, the findings may not be fully transferable to human
neonates due to known variation in the expression of miRNAs in
different species and tissues. However, of all miRNAs, let-7b is
known to be an extremely well-conserved miRNA across various
species, including humans and rodents.
In summary, through miRNA NGS analysis using dried blood
spots of neonates with NE, and both in vitro and in vivo models
of NE, this study highlights the potential importance of let-7b-5p
and YAP in the Hippo pathway, in apoptotic neuronal cell death
in NE. The complex interactions of let-7b-5p with its other targets
and miRNAs warrant further investigation of its role in the
pathophysiology of NE.
Fig. 5 Neuronal expression of let-7b-5p and YAP in normal and glucose-deprived neuronal cells in vitro. a Images of NeuN positive neuronal cells
(green) with let-7b-5p (red) and coexpression is shown (yellow) in the control and glucose-deprived group. Arrows indicate coexpression. b–d Graphs
showing significant decrease in total let-7b-5p (b), neuronal let-7b-5p (c) and the percentage of neuronal let-7b-5p (d) after glucose-derivation compared
to the control group. e Images of NeuN positive neuronal cells (green) with YAP (red) and coexpression is shown (yellow) in the control (arrows indicate
cytoplasm expression) and glucose-deprived group (arrowheads indicate nuclear expression). f–h Graphs showing significant increase in neuronal/nuclear
ratio (f), a significant decrease in nuclear YAP expression (g) and a significant increase in neuronal YAP expression (h) after glucose-derivation compared
to the control group. Error bars represent mean with SEM. n= 4–12. *, **, *** denote significant p < 0.05, p < 0.01, p < 0.001, respectively, using unpaired t
test. Scale bar= 25 μm. CTL control.
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Methods and materials
Clinical cohort. Between January 2014 to January 2016,
neonates > 36 weeks’ gestation were recruited as part of the
BIBiNS (Brain Injury Biomarkers in NewbornS) study from five
UK neonatal units: The Royal London Hospital (Barts Health
NHS Trust), Homerton University Hospital NHS Foundation
Trust, Ashford and St Peter’s Hospitals NHS Foundation Trust,
University Hospital Southampton NHS Foundation Trust, and
Norfolk and Norwich University Hospitals NHS Foundation
Trust. The study was approved by a UK research ethics
Fig. 6 Neuronal apoptosis in the cerebral cortex of the rat neonatal encephalopathy models. a Images of neuronal cells (NeuN positive, green) that can
undergo apoptosis (cleaved caspase-3 positive, red) and coexpression is shown (yellow) in the cerebral cortex of control (arrowheads indicate non-
neuronal apoptotic staining), hypoxic-ischaemic in the ipsilateral (arrows indicate neuronal apoptotic staining) and contralateral region (arrows indicate
neuronal apoptotic staining), and intrauterine inflammation model (arrows and arrowheads indicate neuronal and non-neuronal apoptotic staining,
respectively). b, c Graphs (b) show the statistical significance in cleaved caspase-3 apoptosis and (c) show no statistical significance in neuronal cell
counts co-expressing cleaved caspase-3. Error bars represent mean with SEM (n= 3–6 per group). ns not significant; ** and *** denote significant p < 0.01
and p < 0.001, respectively, using ANOVA with Dunnett’s multiple comparisons test. Scale bar= 50 μm. CTL control, HI hypoxic-ischaemic, ipsi ispsilateral
side, contra contralateral side, IUI intrauterine inflammation.
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committee (London-Bromley, REC ref:13/LO/1738). Neonates
were recruited with written consent from parents.
Neonates with a history of perinatal asphyxia including any
one of the following: need for prolonged resuscitation beyond
10 min of birth; evidence of perinatal acidosis in any blood gas
(umbilical cord or the baby’s) in the first hour with pH < 7.00,
base deficit > 16 mmol/L or high lactate; or an APGAR score of
<5 at 10 min were recruited to the study. All eligible neonates
were categorised prospectively within 6 h into three groups
based on their clinical presentation. Mild NE was defined as
babies with evidence of perinatal acidosis or asphyxia but mild
or no signs of encephalopathy. Babies with moderate to severe
NE had signs of encephalopathy with altered consciousness,
hypotonia, absent or reduced deep tendon reflexes, and/or
seizures.
Group 1 included neonates with a clinical diagnosis of
moderate to severe NE who fulfilled standard cooling criteria43,44
and received TH for 72 h. Group 2 included neonates with mild
Fig. 7 Expression of let-7b-5p in the cerebral cortex in all animal models. a Images of NeuN positive neuronal cells (green) with let-7b-5p expression (red)
and coexpression is shown (yellow) in the cerebral cortex of control (arrows indicate coexpression), hypoxic-ischaemic in the ipsilateral and contralateral
region and intrauterine inflammation model. b Graph showing the statistical significance between the neonatal encephalopathy models vs. control groups
(n= 4–6 per group). c–d Relative expression (2-ΔΔCt) of let-7b-5p (c) and let-7b-3p (d) in peripheral blood in the form of DBS from the rat animal models.
Error bars represent mean with SEM. ns not significant, * and *** denote significant p < 0.05 and p < 0.001, respectively using ANOVA with Dunnett’s multiple
comparisons test. Scale bar= 25 μm. CTL control, HI hypoxic-ischaemic, ipsi ispsilateral side, contra contralateral side, IUI intrauterine inflammation.
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NE admitted to the neonatal unit with perinatal acidosis but did
not satisfy criteria for TH treatment. Group 3 were cord blood
samples from normal pregnancies. Short-term outcome was
obtained for Group 1 neonates who received TH using
conventional T1- and T2-weighted MRI sequences at 1.5 or 3.0
Tesla at the local centres according to unit protocol. Neonates in
Group 1 treated with TH were further divided into 2 subgroups:
those with cerebral MRI predictive of either favourable (Group
1 A) or unfavourable outcome (Group 1B), based on the validated
MRI scoring system17 as previously described16. Additionally,
long-term neurodevelopmental outcome was obtained and
correlated with MRI outcome as detailed in the previous
publication16.
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Samples studied. The neonates who underwent TH (Group 1)
had samples collected at three-time points: sample 1 (S1)
obtained on day 1 after achieving target body temperature of
33.5 °C; sample 2 (S2) obtained between days 2 and 3 during
cooling therapy and prior to commencing rewarming; and sample
3 (S3) obtained on day 5 after rewarming was complete. Group 2
neonates had a single sample collected within 48 h of birth while
Group 3 neonates had umbilical cord samples collected at birth. A
drop of blood was collected at each sample point on an absorbent
filter paper (Whatman 903 protein saver card) to form a DBS and
stored in a polythene bag with a packet of desiccant at room
temperature. Supplementary Fig. 1 shows the grouping of neo-
nates and types of samples collected.
MiRNA next-generation sequencing. Based on the prediction of
generating around 20 million reads per sample, a minimum
sample size of 20 samples was estimated for miRNA NGS ana-
lysis. A cohort of 16 neonates was included, with four per sub-
group selected on the basis of robust clinical grouping and MRI
outcome to provide a total of 32 samples at the three-time points
described above. The clinical characteristics of these neonates are
described in Supplementary Table 1. With 2 × 6 mm DBS chad
and previously published method9 MiRNA NGS was performed
using Illumina Nextseq 500 75 bp single-end high output run45.
Kyoto Encyclopaedia of Genes and genomes pathways analysis.
MiRNA pathway analysis was performed using mirPath V.3 to
predict miRNA targets46. The Kyoto Encyclopaedia of Genes and
Genomes (KEGG) pathways analysis was performed for three
different comparisons through Tarbase V7.0 using pathway
union. This included: 1) mild NE versus moderate to severe NE
with favourable outcome (Supplementary Fig. 2), 2) mild NE
versus moderate to severe NE with unfavourable outcome (Sup-
plementary Fig. 3), and 3) moderate to severe NE with favourable
outcome versus moderate to severe NE with unfavourable out-
come (Supplementary Fig. 4). Reverse Pathway analysis of iden-
tified pathways was also performed for confirmation of the
selected signalling pathway.
Validation using quantitative Reverse Transcription PCR. The
TaqMan microRNA assays for quantitative RT-qPCR was per-
formed according to manufacturer’s protocols as previously
described9. The three potential candidate miRNAs: let-7b-5p
(Assay ID: 000378); let-7b-3p (Assay ID: 002404); and miR-3200-
3p (Assay ID: 241643), plus the endogenous control miRNA miR-
454-5p (Assay ID: 001996) were obtained from our miRNA NGS
study. Validation by RT-qPCR was performed on both the
miRNA NGS cohort and another larger independent cohort.
Cell cultures. Primary mixed cell cultures (containing approx.
27% neurones) from C57BL/6 mice pups at postnatal day 2 were
carried out according to previously published work47. In order to
study cell cultures under conditions of stress, glucose-deprivation
was performed48. Cell cultures at a density of 6000 cells per well
in normal and glucose-deprived conditions were studied using
combined FISH—IHC to identify the microRNA let-7b-5p
expression in neurones using mouse anti-NeuN (1:500,
MAB377, Merck Millipore)49. The cell cultures were double
immunostained for YAP (rabbit anti-YAP, 1:100, 14074 S, Cell
Signaling Technology) and NeuN, with nuclear Hoechst staining
as previously described50.
Rodent models of perinatal brain injury. All animal research
was performed under the EU adopted Directive 2010/63/EU and
reviewed by the local Comité National de Réflexion Ethique sur
l’Expérimentation animale. The in vivo animal experiments for
two established perinatal brain injury models for NE and control
pups were carried out on time-pregnant Wistar rats purchased
from CERJ (Le Genest, France). In the hypoxic-ischaemic model,
pups of either sex at postnatal day 7 were anaesthetised using
isoflurane and a unilateral common carotid artery ligation fol-
lowed by hypoxia in a chamber was carried out as described
before51. After 24 h, the pups were deeply anaesthetised, blood
was collected onto absorbent filter paper as DBS with brains were
dissected and stored in 20% sucrose at 4 °C until further pro-
cessed. The intrauterine inflammation model involved an intra-
peritoneal injection of 300 μg/kg of lipopolysaccharide (E. coli,
serotype 055:B5), to a pregnant rat at 20 days of gestation to
produce inflammation, as previously described52. The blood and
brain tissues were collected from pups on postnatal day 8 as
described earlier. The control animals were from a group of naïve
rat pups that underwent normal pregnancy conditions and were
sacrificed on postnatal day 8 for blood and brain collection
similar to experimental groups.
Ten μm brain sections between Bregma co-ordinates −2.20 to
−0.20 mm containing the cerebral cortex, as shown in the
postnatal rat brain atlas53 were used in this study. The
identification of the cell type that expressed let-7b-5p in the
brain of rat animal models using mouse anti-NeuN (1:500,
MAB377, Merck Millipore) for neurones was carried out using
FISH and IHC, respectively. A similar protocol was used for
double IHC using tyramide amplification for studying neuronal
cell death in the animal models using rabbit anti-cleaved caspase-
3 (1:100, Cat No. 9664, Cell Signaling Technology), and for
expression of YAP in neurones using rabbit anti-YAP (1:200, Cat
No. 14074 S, Cell Signaling Technology). Each animal model
(n= 3–6) had 3–4 brain sections studied and imaged. In the
hypoxic-ischaemic model, the injured side was defined as the
ipsilateral side due to the more focal nature of the insult. In the
intrauterine inflammation model, both left and right sides were
combined together for analysis as the brain was affected globally
by the endotoxin. Similarly, the uninjured control brain was
analysed with combination of data from both the left and right
side. Images were analysed using ImageJ (1.51 v) with a
customised script.
Statistics. Bioinformatics analysis for miRNA NGS data was
performed using Partek® Genomics Suite® software54. Heatmaps
Fig. 8 Neuronal expression of YAP in the cerebral cortex of the rat neonatal encephalopathy models. a Images of NeuN positive neuronal cells (green)
with YAP (red) and coexpression is shown (yellow) in the cerebral cortex of control, hypoxic-ischaemic in the ipsilateral (arrows indicate YAP positive
neurones) and contralateral region (arrows indicate YAP positive neurones), and intrauterine inflammation model (arrows indicate YAP positive neurones).
b Neuronal cytoplasmic YAP positive immunostaining is determined by strong coexpression of NeuN and YAP. c Nuclear YAP positive immunostaining is
determined by strong coexpression of YAP with Hoechst staining in the nucleus. d–f Graphs showing a significant increase in the neuronal/nuclear ratio
(d), significant increase in neuronal (e), but no changes in nuclear (f) YAP expression. Error bars represent mean with SEM. n= 3–6 per group. ns not
significant; ** and *** denote significant p < 0.01 and p < 0.001, respectively, using ANOVA with Dunnett’s multiple comparisons test. Scale bar= 50 μm
for (a) and 10 μm for (b, c). CTL control, HI hypoxic-ischaemic, ipsi ispsilateral side, contra contralateral side, IUI intrauterine inflammation.
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and PCA were performed to identify differentially expressed
miRNAs between the groups and at various time points. Norm-
finder was used to identify miRNAs with the best stability factor,
to be suitable endogenous control miRNAs55. Relative quantifi-
cation of the candidate miRNAs were performed using 2-ΔΔCt
method56. Hierarchical clustering was performed using R
program57. All other data analysis was performed using Graph-
Pad Prism 8. All statistical tests were 2-tailed with a significance
level set with an alpha of 0.05. For continuous variables, statistical
significance between three patient groups was compared using
one-way ANOVA with Dunnett’s post hoc test when comparing
with the control group. For categorical variables, Pearson’s chi-
square and Fisher’s Exact tests were used. For two-group com-
parisons, the Mann–Whitney U test was used for nonparametric
continuous variables while the unpaired t test was used for
parametric data.
Reporting Summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
All miRNA next-generation sequencing data files are available from the Gene Expression
Omnibus with the accession number(s) GSE181127. All other data are included in this
published article (and its supplementary information files).
Code availability
The customised plugins including ‘Channel merging’, ‘Intensity and Co-localisation
analysis’ and “Cell count” macros used in ImageJ analysis to acquire data are available
upon request.
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